T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease

Clinical and Experimental Rheumatology

Volumn 22, Issue 4 SUPPL. 24, 2004, Pages

  Kibaroglu, A ^a   Eksioglu Demiralp, E ^a   Akoglu, T ^a   Direskeneli, H ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Behcet's disease; Escherichia coli; Human HSP60; Streptococcus

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COLCHICINE; CROSS REACTING ANTIGEN; HEAT SHOCK PROTEIN 60; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; CHAPERONIN 60; HLA B51 ANTIGEN; MEMBRANE ANTIGEN; BACTERIAL ANTIGEN; CHAPERONIN; BACTERIAL PROTEIN; EPITOPE;

ADULT; ARTICLE; BEHCET DISEASE; CELL CULTURE; CELL STIMULATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VIVO STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STREPTOCOCCUS SANGUINIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANTIGEN EXPRESSION; BACTERIAL STRAIN; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; PATHOGENESIS; T LYMPHOCYTE; UPREGULATION; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; CLINICAL OBSERVATION; CROSS REACTION; CULTURE MEDIUM; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; NONHUMAN; STATISTICAL SIGNIFICANCE;

ADULT; ANTIGENS, BACTERIAL; BEHCET SYNDROME; CELLS, CULTURED; CHAPERONIN 60; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 6344232025     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
2. DIRESKENELI H: Review: Behçet's disease: Infectious etiology, new auto-antigens and HLA-B51. Ann Rheum Dis 2001; 82:996-1002.
3. LEHNER T: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 1997; 14: 21-32.
4. The Behcet's Disease Research Committee of Japan: Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease - A multicenter study. J Rheumatol 1989; 16: 506-11.
5. CALGUNERI M, KIRAZ S, ERTENLI I, BENEKLI M, KARAASLAN Y, CELIK I: The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial. Arthritis Rheum 1996; 39: 2062-65.
6. KANEKO F, OYAMA N, NISHIBU A: Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38: 444-54.
7. ISOGAI E, OHNO S, KOTAKE S et al.: Chemiluminescense of neutrophils from patients with Behcet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol 1990; 35: 43-8.
8. MIZUSHIMA Y, MATSUDA T, HOSHL K, OHNO S: Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol 1988; 15: 1029-30.
9. HIROHATA S, OKA H, MIZUSHIMA Y: Streptococcal-related antigens stimulate production of IL-6 and interferon-gamma by T cells from patients with Behçet's disease. Cell Immunol 1992; 140: 410-19.
10. BANK I, DUVDEVANI M, LIVNEH A: Expansion of γδ T-cells in Behçet's disease: Role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003; 141: 33-41.
11. NISHIDA T, HIRAYAMA K, NAKAMURA S, OHNO S: Proliferative response of CD8+ gamma delta+ T cells to Streptococcus sanguis in patients with Behçet's disease. Ocul Immunol Inflamm 1998; 3: 139-44.
12. MOCHIZUKI N, SUZUKI N, TAKENO M et al.: Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis. Eur J Immunol 1994; 24: 1536-43.
13. YOSHIKAWA K, KOTAKE S, KUBOTA T, KIMURA K, ISOGAI E, FUJII N: Cloning and sequencing of BES-1 gene encoding the immunogenesis antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behçet's disease. Zent Bl Bakteriol 1998; 287: 449-60.
14. HIROHATA S, HASHIMOTO T: Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD). Clin Exp Immunol 1998; 112: 17-24.
15. DIRESKENELI H, SARUHAN-DIRESKENELI G: The role of heat-shock proteins in Behcet's disease. Clin Exp Rheumatol 2003; 21: S44-S48.
16. LEHNER T, LAVERY E, SMITH R, van der ZEE R, MIZUSHIMA Y, SHINNICK T: Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behç et's syndrome. Infect Immun 1991; 59: 1434-41.
17. HASAN A, FORTUNE F, WILSON A et al.: Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996; 347: 789-94.
18. KANEKO S, SUZUKI N, YAMASHITA N et al.: Characterization of T cells specific for an epitope of human 60 kD heat shock protein (hsp) in patients with Behçet's disease in Japan. Clin Exp Immunol 1997; 108: 204-11.
19. DIRESKENELI H, EKSIOGLU-DEMIRALP E, YAVUZ S et al.: T cell responses to 60/65 kD HSP derived peptides in Turkish Behç et's disease patients. J Rheumatol 2000; 27: 708-13.
20. International Study Group For Behcet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990; i: 1078-80.
21. EKSIOGLU-DEMIRALP-E, DIRESKENELI H, ERGUN T, FRESKO I, AKOGLU T: Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease. Rheumatol Int 1999; 19: 23-6.
22. LEVITZ MS, MATHEWS HL, MURPHY JW: Direct anti-microbial activity of T cells. Immunol Today 1995; 16: 387-91.
23. VERGELLI M, LE H, van NOORT JM, DHIBJALBUT S, McFARLAND H, MARTIN R: A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. J Immunol 1996; 157: 679-88.
24. BARNABU U, FRANCO A, PAROLI M, BENVENUTO R, FERRARINI M: Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152: 3074-87.
25. DUMMER R, POTOCZNA N, HAFFNER AC, ZIMMERMANN DR, GILARDI S, BURG G: A primary cutaneous non-T, non-B CD4+ CD56+ lymphoma. Arch Dermatol 1996; 132: 550-3.
26. HAMZAOUI K, AYED K, HAMZA M, TOURAINE JL: Natural killer cells in Behcet's disease. Clin Exp Immunol 1988; 71: 126-31.
27. KANEKO F, TAKAHASHI Y, MURAMATSU R, ADACHI K, MIURA Y, NAKANE A, MINAGAWA T: Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br J Dermatol 1985; 113: 313-8.
28. DIRESKENELI H, EKSIOGLU-DEMIRALP E, KIBAROGLU A, YAVUZ S, ERGUN T, AKOGLU T: Oligoclonal T cell expansions in patients with Behcet's disease. Clin Exp Immunol 1999; 117: 166-70.
29. FREYSDOTTIR J, LAU SH, FORTUNE F: Gamma delta+ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999; 118: 451-7.
30. ESIN G, SHIGEMATSU M, NAGAI S, EKLUND A, WIGZELL H, GRUNEWALD J: Different percentages of peripheral blood γδ+ T cells from different areas of the world. Scand J Immunol 1996; 43: 593-6.